Glossary

Out-of-Specification (OOS) Result

Upper spec limit
Illustration

A test result that falls outside the specification or acceptance criteria in the marketing application, the pharmacopoeia, or the manufacturer's own standard.

Source · WHO TRS 1052, Annex 4, WHO good practices for pharmaceutical quality control laboratories, Glossary, Out-of-specification result

Details

An OOS is a test result outside specification, and the original result cannot be invalidated on the hypothesis of laboratory error alone. Inspections cite retesting without a scientific hypothesis, selection of the favourable result, and investigations not extended to the manufacturing process or to other batches. Check the raw data and audit trail, the calculations and the state of the equipment, the phased OOS investigation, the batch impact assessment, and CAPA.

Related sections

Related terms

Real inspection findings

Findings from regulators' inspection documents in which this term appears.

  1. For example, our investigators observed partially completed and torn-up manufacturing records for a lot of children’s acetaminophen and stacks of loose printed…
    FDA · FDA Warning Letter · 2023-09-12
  2. Deficiencies were also raised in the management of documentation, traceability of GMP activities, deviations, OOS.
    EMA · EU GMP NCR (EudraGMDP) · 2025-12-04
  3. Regarding your failure to conduct adequate investigations, our comprehensive review of your firm’s multiple deviation reports and SOPs reveals significant deficiencies in documentation and execution procedures for out-of-specification (OOS) events and deviation investigations.
    FDA · FDA Warning Letter · 2026-05-12
See 368 findings whose text contains this term

Counted as of 2026-09-24 — the search you land on shows today's figures, so it may differ slightly.

Source

WHO TRS 1052, Annex 4, WHO good practices for pharmaceutical quality control laboratories, Glossary, Out-of-specification result

GRM Regulatory Glossary

243 GMP terms in one place

Each term is explained in plain language with its official source. Look it up here whenever you meet a term you don't know.

Browse the whole glossary
Weekly Newsletter

New GMP inspection findings, every Monday

Every Monday we email the week's new inspection records from the FDA, EMA, Health Canada and MFDS, with a short summary of the week's regulatory news. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.